Updated Jul 16, 2026
Rachman Ilya M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-10 | IMMX | Immix Biopharma, Inc. | P — Open-market purchase | 746 | $6.67 | $5K |
| 2025-09-17 | IMMX | Immix Biopharma, Inc. | P — Open-market purchase | 2.5K | $2.02 | $5K |
Rachman Ilya M is a corporate insider — currently tracked as CEO and Chairman, Director of Immix Biopharma, Inc. (IMMX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rachman Ilya M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.